Ryan M. Confer Email & Phone Number

Austin, Texas, US

Genprex (NASDAQ::GNPX) is a clinical-stage biopharmaceutical company focused on the development of novel gene therapies for patients with cancer and diabetes who have limited treatment options. The Company works with world-class research institutions to identify and advance emerging and disruptive therapies.Genprex’s oncology program utilizes a unique.

Austin, Texas, US

Austin, Texas, US

Austin, Texas, US

Austin, Texas, US

I worked closely with founding CEO, David Nance (former CEO of Introgen Therapeutics), to build a strategic business and financial plan to launch the company and seek early-stage investment.

Austin, Texas, US

Gurnade is a creative design agency and automotive tuner. The Company's bread-and-butter is the development of hyper-realistic conceptual designs and their subsequent conversion into high-quality products (what industry refers to as "render to reality"). Our quality craftsmanship has lead to collaboration and partnerships with some of the most reputable.

Confer Capital, Inc is a technology-focused advisory services boutique with a focus on transitioning ideas thru commercialization. We have specialized client advisors that have broad and focused advisory in industries including biopharma, medical devices, SaaS, oil & gas, and financial services. Our core competencies include: negotiating technology.

• Innovate Texas Foundation connects Texas's wealth of intellectual capital with financial capital, human capital, entrepreneurs, universities, businesses, government, and technology communities to strengthen Texas as a.
• Mission & strategy endorsed in July 2008 State of Texas' Competitiveness Councils (nominated by Gov Rick Perry) Report;
• Spearheaded research of >3000 Texas stakeholders determining lack of access to innovation resources;
• Raised over $2M funding from Department of Labor grants & private donors to launch organization;
• Mentored & advised over 250 technology commercialization projects & start-up companies;
• Completed over 20 professional and executive training seminars on the topics of technology transfer, development, and commercialization to approximately 1000 attendees from 2009 to 2011;

• Active Manager of a portfolio of 120+ early-stage start-up companies for a $500M+ early-stage technology investment fund;
• Researched emerging technologies, markets, and industries to support due diligence and investment screening;
• Managed relationships and trained eight regional commercialization deal-flow centers (RCICs) on investment screening best practices;
• Negotiated deals and determined value-driven contractual milestones to trigger funding tranches;
• Maintained cap tables, developed financial models, and developed portfolio management processes and metrics to monitor investment risk and evaluate deal and fund performance; and
• Recognized nationally as the "Most Active Early-Stage Technology Venture Fund in the United States." - June 2008

• Performed financial analysis on over $2B in proposals to the Industrial Revenue Bond Program (IRB);
• Developed liquidity & default risk provisions and a tiered lending structure for the Texas Leverage Fund (TLF);
• Developed and proposed a revised operations and investment strategy for the Product Development & Small Business Incubator Programs (PDSBI);
• Performed analysis and developed financial models for over $50M in proposals to the Texas Enterprise Fund (TEF); and
• Trained finance team members on the development and usage of financial models to conduct analysis.

Master Of Science In Technology Commercialization, Entrepreneurship

Bsba, Finance & Legal Studies

Finance And Economics